Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people lose between half a kilogram and two kilograms in their first month on Wegovy. That figure sounds modest, and a lot of patients feel deflated by it — but it's exactly what the clinical evidence predicts, and it's also often the most important month of the whole process. Wegovy is a prescription-only medicine requiring clinical assessment before it can be prescribed; a qualified prescriber decides whether it's appropriate for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Here's the misconception our prescribers field most weeks: people arrive expecting to see a dramatic drop on the scales by the end of the first injection pen. It's understandable, the headline trial figures for Wegovy (around 15% average body weight reduction over 68 weeks in the STEP 1 trial, published in the New England Journal of Medicine) are genuinely impressive. But that's 68 weeks, not four.
In practice, month one on Wegovy is 0.25mg, the starting dose, which exists to let your system adjust, not to drive weight loss. Most of the early weeks involve your body getting used to the medicine: nausea is common, appetite suppresses gradually, and the calorie deficit that produces fat loss builds slowly. Our guide to Wegovy weight loss per month walks through how results typically shift as you move through the titration schedule toward the 1.7mg and 2.4mg maintenance doses. If you're wondering how much weight loss to realistically expect from Wegovy in a month, the answer changes considerably as you move through the titration schedule toward the 1.7mg and 2.4mg maintenance doses. Expecting a stone in thirty days sets people up to abandon a treatment that, given time, genuinely works for many.
The fact: modest early progress is normal. Clinically, a loss of 0.5–2kg in the first four weeks is consistent with how the medicine is designed to work. Some people see a little more; some see less. Both are within normal range at this stage.
Private Wegovy pricing in the UK is quoted per pen (one pen covers four weekly injections at your current dose). Reported market prices vary by dose and provider, and they have shifted since Eli Lilly's September 2025 list-price rise affected the broader GLP-1 market, comparable private treatments now typically range from around £149 to £375 per month depending on the dose and where you go. You can find a fuller breakdown of what monthly Wegovy pricing actually reflects on our cost explainer.
What matters is what a given price includes. Many headline figures you'll see advertised cover the pen only. Add a separate consultation fee, a prescription charge, delivery, and any ongoing clinical support, and the real monthly outlay is meaningfully higher. Some providers charge per dose review or bill for aftercare calls. None of that is listed on the banner.
A legitimate private Wegovy service also has to cover the infrastructure that makes it safe: identity checks, weight verification, prescriber oversight, and access to clinical support if something goes wrong. These aren't optional extras, they're the minimum a regulated pharmacy is expected to provide. See how private Wegovy pricing is structured for a clearer sense of what to look for.
At nume, we're not the cheapest, that's a deliberate position, not a gap we've overlooked. One price covers your consultation, prescription, treatment, and free next-working-day tracked delivery, with priority clinical aftercare available seven days a week. There is no subscription. Every repeat order goes back in front of a real prescriber before anything is sent. You can verify our GPhC registration at the GPhC register (premises number 9012878), that takes about ten seconds and is worth doing for any online pharmacy you consider.
For a full picture of what's included and current treatment pricing, the weight-loss treatments page is the right place to start. We never print per-pen prices in body copy, because a price without clinical context is just a number.
The MHRA has warned publicly about fake weight-loss pens sold online, some of which have contained insulin rather than semaglutide. Enforcement in 2025 included seizures of approximately 20 million doses of illegally traded weight-loss medicines. These products often reach buyers through social-media sellers offering prices well below the market rate, occasionally with discount codes attached.
nume does not run discount codes, vouchers or promotional pricing for prescription medicines. If you see a code being offered for Wegovy or Mounjaro from an unverified seller, treat it as a red flag rather than a saving. The NHS England guidance on weight-management injections sets out clearly what a safe, supervised treatment pathway looks like.
For a weight-loss medicine that works over months, not weeks, the sensible metric isn't price per pen, it's whether the clinical support around it is real. You can read more about realistic total weight loss on Wegovy to understand the full trajectory, and more about how nume operates if you want to understand who is reviewing your case.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.